Genome-wide in vivo CRISPR screens identify GATOR1 as a TP53 induced tumour suppressor
Mizutani, S.; Potts, M. A.; Deng, Y.; Giner, G.; Diepstraten, S.; Kueh, A. J.; Pal, M.; Healey, G.; Tai, L.; Wilcox, S.; Wei, A.; Pomilio, G.; Liao, Y.; Papenfuss, A. T.; Kelly, G. L.; Shi, W.; Strasser, A.; Herold, M. J.
Show abstract
Identifying tumor suppressor genes is predicted to inform on the development of novel strategies for cancer therapy. To identify new lymphoma driving processes that cooperate with oncogenic MYC (which is abnormally highly expressed in [~]70% of human cancers) we have used a genome-wide CRISPR knockout screen in E{micro}-Myc;Cas9 transgenic hematopoietic stem and progenitor cells in vivo. We discovered that loss of any of the GATOR1 complex components - NPRL3, DEPDC5, NPRL2 - significantly accelerated c-MYC-driven lymphoma development in mice. Low expression of the GATOR1 complex genes correlated with poor survival outcomes for human patients with high MYC- expressing cancers. Murine lymphomas lacking GATOR1 were highly sensitive to mTOR inhibitors as a single agent therapy, both in vitro and in vivo. These findings identify inhibition of mTORC1 as a potent tumor suppressive mechanism in c-MYC-driven lymphomagenesis and suggest a new avenue for therapeutic intervention in GATOR1-deficient lymphomas through mTOR inhibition. Key PointsO_LIIn vivo CRISPR/Cas9 whole genome knockout screens identified the GATOR1 complex as a potent suppressor of c-MYC-driven lymphomagenesis. C_LIO_LIGATOR1 deficiency in MYC-driven lymphomas confers sensitivity to mTOR inhibition, suggesting a novel therapeutic approach. C_LI
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Alternative splicing of its 5'-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies 96%
- MondoA Drives Malignancy in cALL through Enhanced Adaptation to Metabolic Stress 96%
- Targeting DOT1L and EZH2 synergizes in breaking the germinal center identity of Diffuse Large B Cell Lymphoma 96%
Similar papers in this journal
- ATP citrate lyase is an essential player of the metabolic rewiring induced by PTEN loss during T-ALL development. 96%
- Lfc/Arhgef2 regulates mitotic spindle orientation in hematopoietic stem and progenitor cells and is essential for productive hematopoiesis 94%
- Modeling IKZF1 lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilities 94%
Similar papers in this journal
- EZH2 mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibition 95%
- A single cell atlas reveals distinct immune landscapes in transplant and primary tumors that determine response or resistance to immunotherapy 95%
- ARF6-dependent endocytic trafficking of the Interferon-γ receptor drives adaptive immune resistance in cancer. 95%
Similar papers in this journal
- HDAC1 acts as tumor suppressor in ALK-positive anaplastic large-cell lymphoma: Implications for HDAC inhibitor therapy 95%
- Low-affinity CAR T cells exhibit reduced trogocytosis, preventing fratricide and antigen-negative tumor escape while preserving anti-tumor activity 94%
- Enhanced differentiation of functional human T cells in NSGW41 mice with tissue-specific expression of human interleukin-7. 94%
Similar papers in this journal
- Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance 96%
- Rapid and specific degradation of endogenous proteins in mouse models using auxin-inducible degrons 94%
- Non-canonical H3K79me2-dependent pathways promote the survival of MLL-rearranged leukemia 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.